Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $7.9 million.

  • Evogene's Consolidated Net Income rose 63881.71% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $421000.0, marking a year-over-year increase of 10244.7%. This contributed to the annual value of -$3.2 million for FY2024, which is 8752.79% up from last year.
  • Latest data reveals that Evogene reported Consolidated Net Income of $7.9 million as of Q3 2025, which was up 63881.71% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, Evogene's Consolidated Net Income peaked at $7.9 million during Q3 2025, and registered a low of -$9.8 million during Q2 2022.
  • Its 5-year average for Consolidated Net Income is -$5.0 million, with a median of -$6.9 million in 2021.
  • As far as peak fluctuations go, Evogene's Consolidated Net Income tumbled by 9201.78% in 2023, and later soared by 63881.71% in 2025.
  • Over the past 5 years, Evogene's Consolidated Net Income (Quarter) stood at -$8.1 million in 2021, then soared by 52.73% to -$3.8 million in 2022, then crashed by 92.02% to -$7.3 million in 2023, then soared by 86.53% to -$988000.0 in 2024, then surged by 902.23% to $7.9 million in 2025.
  • Its Consolidated Net Income stands at $7.9 million for Q3 2025, versus -$3.5 million for Q2 2025 and -$3.0 million for Q1 2025.